'Excellent Results' From Quebec Project Drilling: Analyst
Source: Streetwise Reports  (7/13/21)
The latest batch of drill results from Troilus Gold's namesake project is presented and interpreted in a Red Cloud Securities report. More >

Explorer Starts to Drill Test Carlin-Type Mineralization in Nevada
Source: Streetwise Reports  (7/13/21)
For this follow-up phase of drilling at its Alpha project in Nevada, Sitka Gold plans a minimum of 1,500 meters. More >

Corvus Gold Receives Non-Binding Cash Buyout Bid from AngloGold Ashanti
Source: Streetwise Reports  (7/13/21)
Corvus Gold's U.S. ADR shares rose by 21% after the company reported it received an unsolicited buyout offer from AngloGold Ashanti Ltd. for CA$4.00 per share in cash. More >

Update on 'One of the More Interesting Hybrid Prospect Generators Out There'
Source: The Critical Investor for Streetwise Reports  (7/13/21)
The Critical Investor discusses Kenorland Minerals' recent activities: completing its first drill program at Regnault; ongoing exploration at Tanacross, Chebistuan and Healy; and the sale of the Fox property. More >

Ring of Fire Gold Explorer Earns DTC Eligibility for US Electronic Trading of Shares
Source: Streetwise Reports  (7/12/21)
Kalo Gold Holdings Corp. reported its common shares have met the eligibility requirements established by the Depository Trust Company for electronic clearing and settlement in the U.S. More >

Alphatec Shares Rise After Firm Announces Strong Organic Revenue Growth in Q2
Source: Streetwise Reports  (7/12/21)
Alphatec Holdings Inc. shares traded 12% higher after the company reported preliminary Q2/21 financial results that included a larger than 90% increase in YoY organic revenue. More >

GATA: The Original Whistleblowers
Source: Michael Ballanger for Streetwise Reports  (7/12/21)
Sector expert Michael Ballanger discusses the history of the Gold Anti-Trust Action Committee and its importance to investment in the precious metals. More >

Maxtech Ventures: Primed to Prove Up a Potential 1 Moz Maiden Gold Resource in Ontario
Source: The Critical Investor for Streetwise Reports  (7/12/21)
The Critical Investor profiles Maxtech Ventures and explains why there is realistic potential for a strong re-rating. More >

Cypress Development Corp. De-risks Flagship Project with Direct Lithium Extraction Partner
Source: Peter Epstein for Streetwise Reports  (7/12/21)
Peter Epstein of Epstein Research explains why he believes there will be significant lithium production from the U.S. and the role that Cypress Development could play. More >

PEA 'Signals Doubling of Production' for Potential Uranium Takeout Target
Source: Streetwise Reports  (7/9/21)
An Eight Capital report raises its target price on Azarga Uranium after the company released a preliminary economic assessment on its Gas Hills uranium project. More >

Pharma Company Working to Unlock Psychedelic Drug's Potential for Stroke Recovery
Source: Streetwise Reports  (7/9/21)
Algernon Pharmaceuticals CEO Christopher J. Moreau and Dr. David Nutt, the company's research stroke consultant, discuss Algernon's upcoming Phase 1 study of DMT for stroke. More >

Stamps.com Shares Soar on $6.6 Billion Buyout Bid from Private Equity Firm
Source: Streetwise Reports  (7/9/21)
Shares of Stamps.com Inc. traded 64% higher after the company reported it entered into a definitive agreement to be acquired by Thoma Bravo for $330 per share in cash. More >

Coverage Initiated on 'A Different Kind of Royalty Company with Upside Potential'
Source: Streetwise Reports  (7/8/21)
The factors making Empress Royalty an attractive investment are delineated in a Research Capital Corp. report. More >

Four Potential Takeover Targets on This Precious Metals Fund Manager's List
Source: Streetwise Reports  (7/8/21)
Ralph Aldis, portfolio manager at U.S. Global Investors, explains why he believes we are not in a full-fledged gold market yet and discusses where he believes investors can find opportunities. More >

Gold: Bear or Bull Market?
Source: Michael Ballanger for Streetwise Reports  (7/8/21)
In honor of Independence Day, sector expert Michael Ballanger celebrates the American "tribe," and also reflects on a potential precious metals bear market. More >

Quebec Junior Sets 2 Moz Gold Resource as Goal
Source: Streetwise Reports  (7/8/21)
Quebec Precious Metals Corporation (QPM) has set the resource bar at 2 million ounces. QPM management believes that's the minimum threshold necessary to attract the interest of major gold producers. The initial resource estimate at Sakami, set to hit the market late in 2021, will tell the tale. More >

Group 1 Automotive's Q2 US Vehicle Unit Sales Up 11-12% Over Pre-Covid 2019 Volumes
Source: Streetwise Reports  (7/8/21)
Group 1 Automotive shares powered 8% higher after the company reported preliminary consolidated new and used vehicle sales of 87,600 units during Q2/21. More >

Biopharma Files New Drug Application for Lead Clinical Product
Source: Streetwise Reports  (7/7/21)
A review of Daré Bioscience's lead clinical product for bacterial vaginosis and a potential timeline to commercialization are provided in a Roth Capital Partners report. More >

Biotech 'Strikes Again,' Identifies Gene Mutation that Protects Against Obesity
Source: Streetwise Reports  (7/7/21)
The encouraging work Regeneron Pharmaceuticals completed thus far, and the next challenge in this program, are laid out in an H.C. Wainwright & Co. report. More >

Gold Stock Looking Ready to Reverse to the Upside
Source: Clive Maund for Streetwise Reports  (7/7/21)
Technical analyst Clive Maund charts Sitka Gold and explains why he sees it as a speculative buy. More >

FenixOro Gold Undervalued, Trading at <1% of the Value of Nearby Buriticá Mine
Source: Peter Epstein for Streetwise Reports  (7/7/21)
Peter Epstein of Epstein Research explains why he believes FenixOro "offers a compelling high-risk/high-reward investment proposition." More >

Biohaven Posts Revenue of $93 Million in Q2 for Its Migraine Medicine
Source: Streetwise Reports  (7/7/21)
Shares of Biohaven Pharmaceutical Holding Co. Ltd. traded 12% higher to a new 52-week high after the company reported preliminary Q2/21 net product revenue of $93 million for NURTEC ODT, which it claims is the first and only FDA approved medicine for both acute and preventive migraine treatment. More >

Technical Analyst Sees Bullish Signal for Mining Junior
Source: Clive Maund for Streetwise Reports  (7/7/21)
Technical analyst Clive Maund explains why he has a Buy recommendation for Barsele Minerals. More >

Helium Exploration & Development Company Offers 'Key Advantages'
Source: Streetwise Reports  (7/6/21)
An Eight Capital initiation report details the factors that make Imperial Helium attractive. More >

Positive Project PEA Makes Uranium Company 'Two Trick Pony,' Says Analyst
Source: Streetwise Reports  (7/6/21)
The preliminary economic assessment for Azarga Uranium's Gas Hills project and what it means for the company are discussed in a Haywood Securities report. More >